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Abstract 21 
This study characterizes the antioxidant and antibacterial properties of a 22 
propolis-based dietary supplement (PDS) and investigates its incorporation into apple 23 
juice to decrease the intensity of the heat treatment required to inactivate 5 log10 cycles 24 
of Escherichia coli O157:H7. As the source of propolis, we used a PDS containing 0.2 25 
mg/µL of propylene glycol-extracted propolis (propolis). The total phenolic content and 26 
antioxidant activity (IC50) of the PDS were 82.15 ± 3.53 mg/g and 0.055 ± 0.003 27 
mg/mL, respectively. Regarding antimicrobial activity, propolis (0.2 mg/mL) was very 28 
effective under acidic pH against Listeria monocytogenes EGD-e, inactivating more 29 
than 5 log10 cell cycles in 1 h, but hardly inactivated or sub-lethally injured E. coli 30 
O157:H7 Sakai. However, incorporating propolis (0.2 mg/mL) into acidic buffer 31 
decreased the time needed to inactivate 5 log10 cycles of E. coli O157:H7 Sakai at 51 °C 32 
by 40 times. Moreover, when combined with heat in apple juice, propolis (0.1 mg/mL) 33 
reduced the thermal treatment time and temperature needed to inactivate 5 log10 cycles 34 
of E. coli by 75% and 3 °C, respectively. The corresponding PDS concentration did not 35 
decrease the organoleptic properties of the apple juice, which implies the possibility of 36 
obtaining a sensorially appealing, low-pasteurized apple juice with the functional 37 
properties provided by propolis. 38 
 39 
Keywords: Propolis, Bioactive properties, Escherichia coli O157:H7, Heat, 40 
Apple juice, Sensory analysis  41 
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1. Introduction 42 
Propolis is a bee product collected by honeybees (Apis mellifera L.) from tree 43 
buds; it is used in beehives as a protective barrier against pathogenic microorganisms 44 
(Silva et al., 2012). In general, it is composed of 50% resin and vegetable balsam, 30% 45 
wax, 10% essential and aromatic oils (EOs), 5% pollen, and 5% various other 46 
substances, including organic debris (Marcucci, 1995).  47 
Considering its role as bees’ chemical weapon, it is no surprise that propolis has 48 
been subjected to intensive studies describing its antibacterial, antiviral, antifungal, 49 
antioxidant, anti-inflammatory, immunostimulating, and anticancer properties (Silva et 50 
al., 2012). Due to these properties, alongside consumers’ growing demand for “green 51 
products,” and the fact that its main constituents are generally recognized as safe 52 
(GRAS) substances (Burdock, 1998), propolis is gaining popularity as a natural 53 
preservative for new food applications and is being added to foods and drinks as a 54 
source of bioactive compounds to improve health (Mishima et al., 2005; Moreira et al., 55 
2008). 56 
On the other hand, extensive research is being carried out to develop new 57 
preservation methods, in an attempt to achieve food safety goals while maintaining high 58 
sensorial and nutritional food quality. According to the “hurdle theory” proposed by 59 
Leistner and Gorris (1995), the combination of a low-intensity thermal treatment and 60 
antimicrobial compounds could provide an enhanced antimicrobial effect, resulting in 61 
fewer undesirable effects. Previously, our research group explored the application of 62 
combined preservation processes based on the simultaneous action of mild heat and 63 
natural substances of vegetable origin, such as essential oils (EOs) and their 64 
constituents, observing synergistic effects (Espina et al., 2011; Espina et al., 2010; 65 
Espina et al., 2012; Somolinos et al., 2010). On the other hand, propolis has been 66 
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suggested to act synergistically with heat in meat products (Kim et al., 2014), which 67 
might be related to presence of EO constituents (such as terpenoids and phenolic 68 
compounds) (Burt, 2004; Kumazawa et al., 2004). 69 
This potential synergism between propolis and heat could be exploited to design 70 
preservation treatments for heat-sensitive and sweet-flavored foods, such as apple juice, 71 
so that thermal treatments could be applied at lower intensity. Moreover, the 72 
preservation of apple juice needs to be improved, as it has been involved in recent 73 
outbreaks of E. coli O157:H7 (Parish, 2009). Because this microorganism has been 74 
pointed out as the most heat- and acid-resistant pathogen in acidic juices (Mazzotta, 75 
2001), the Food and Drug Administration’s Guidance for Industry implemented a rule 76 
requiring that all apple juice producers achieve a 5-log10 reduction of E. coli O157:H7 77 
to ensure the safety of their product (FDA, 2001). 78 
Therefore, this study was conducted to characterize a propolis-based dietary 79 
supplement (PDS) containing 0.2 mg/µL of propylene glycol–extracted propolis 80 
(propolis) and evaluate its possible use as a natural additive in apple juice. More 81 
specifically, the aims of this work were (i) to characterize the bioactive properties of 82 
PDS (in terms of phenolic content and antioxidant activity), (ii) evaluate the 83 
effectiveness of propolis against Gram-positive and Gram-negative representative 84 
bacteria (L. monocytogenes and E. coli, respectively), (iii) evaluate its use in 85 
combination with mild heat to inactivate 5 log10 cycles of E. coli O157:H7 cells in apple 86 
juice, and (iv) determine the hedonic acceptability of apple juice with propolis. 87 
 88 
2. Material and Methods 89 
 90 
2.1. Propolis sample 91 
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The sample used in this investigation was a dietary food supplement containing 92 
raw propolis provided by Miel El Albar (Lechón, Zaragoza, Spain). According to the 93 
producer, the main plant species that contributed to the propolis were poplar (Populus 94 
spp.), oak (Quercus spp.), and pine (Pinus spp.). The raw propolis was collected and 95 
macerated for 48 h under agitation at 36 ºC in propylene glycol. Wax and debris were 96 
removed by double filtration, obtaining a tincture (the propolis-based dietary 97 
supplement, PDS). The final concentration of propolis in PDS was 0.2 mg/µL. 98 
 99 
2.2. Analysis of bioactive compounds and determination of antioxidant activity of the 100 
propolis-based dietary supplement 101 
 The total polyphenol content (TPC), flavonoid content (FC), and 2, 2-diphenyl-102 
1-picryl-hydrazyl-hydrate (DPPH) free radical-scavenging activity were determined by 103 
analyzing 6 replicates of the same sample. Spectrophotometric lectures were carried out 104 
in a Helios Gamma Thermo Electron Corporation Spectrophotometer (United 105 
Kingdom).  106 
The TPC was determined by the Folin–Ciocalteu method (Millena Popova, 107 
Silici, Kaftanoglu, & Bankova, 2005). One mL of a test solution of PDS was transferred 108 
to a 50-mL volumetric flask containing 15 mL distilled water and 4 mL of the Folin–109 
Ciocalteu reagent (Panreac, Spain); 6 mL of a 20% sodium carbonate solution (w/v) 110 
(sodium carbonate anhydrous, Panreac, Spain) were then added. The rest of the volume 111 
was made up with distilled water to 50 mL. After 2 h, the absorbance was measured at 112 
760 nm. A blank solution was included in each assay, with 1 mL of methanol (Labscan, 113 
Poland) instead of the test solution. A calibration curve of standard caffeic acid (Sigma-114 
Aldrich, USA) was employed (10–50 mg/mL; y = 0.0055x − 0.0283; R2 = 0.9984). The 115 
results were expressed as mg caffeic acid equivalents (CAEs)/g PDS.  116 
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The aluminum chloride method (Silva et al., 2012) was used to determine the 117 
FC. Briefly, 250 µL of a test solution of PDS were mixed with 1.25 mL of distilled H2O 118 
and 75 µL of a 5%-NaNO2 solution (sodium nitrite, Panreac, Spain). After 5 min, 150 119 
µL of a 10%–AlCl3 H2O solution (aluminum chloride hexahydrate, Panreac, Spain) was 120 
added. After 6 min, 500 µL of 1-M NaOH (Panreac, Spain) and 275 µL of distilled H2O 121 
were added to the mixture. The solution was well mixed, and the intensity of pink color 122 
was measured at 510 nm. In an analogous procedure, 250 µL of a blank solution was 123 
used instead of the test solution. Catechin (Sigma-Aldrich, USA) standard solutions 124 
(0.01–0.09 mg/mL) were used to construct the calibration curve (y = 3.7300 x − 0.0098; 125 
R2 = 0.9998). The results were expressed as mg catechin equivalents (CEs)/g PDS. 126 
The DPPH free radical method is an antioxidant assay based on electron transfer 127 
that produces a violet solution in ethanol. This free radical, which is stable at room 128 
temperature, is reduced in the presence of an antioxidant molecule, giving rise to a 129 
colorless ethanol solution. The use of the DPPH assay provides an easy and rapid way 130 
to evaluate antioxidants by spectrophotometry. This test was performed as described by 131 
Miguel et al. (2010). 50 µL of different concentrations of PDS were added to 2 mL of 132 
60-µM methanolic solution of DPPH (Sigma-Aldrich, USA). The absorbance 133 
measurements were read at 517 nm, after 20 min of incubation time at room 134 
temperature (A1). The absorption of a blank sample containing the same amount of 135 
methanol and DPPH solution acted as the negative control (A0). The percentage 136 
inhibition [(A0 – A1 / A0) * 100] was plotted against the different concentrations of the 137 
commercial sample. IC50 was determined (mg/mL) as the concentration of the 138 
commercial sample able to scavenge 50% of DPPH free radicals. The results were 139 
expressed as IC50 (mg/mL) of PDS. 140 
 141 
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2.3. Micro-organisms and growth conditions 142 
E. coli O157:H7 Sakai stx 1A-/stx 2A- was kindly provided by Kyu-Tae Chang 143 
(The National Primate Research Center, KRIBB, Ochang, South Korea). This strain was 144 
isolated from an outbreak involving white radish sprout (Michino et al., 1999). L. 145 
monocytogenes EGD-e was kindly provided by Prof. Chakraborty (Institute for Medical 146 
Microbiology, Giessen, Germany). During this investigation, the cultures were 147 
maintained and kept frozen at −80 °C in cryovials. Broth subcultures were prepared by 148 
inoculating one single colony from a plate into a test tube containing 5 mL of sterile 149 
tryptic soy broth (Biolife, Milan, Italy) with 0.6% yeast extract added (Biolife) 150 
(TSBYE). After inoculation, the tubes were incubated overnight at 37 °C (E. coli 151 
O157:H7 Sakai) or 30 ºC (L. monocytogenes EGD-e). Along with these subcultures, 152 
250-mL Erlenmeyer flasks containing 50 mL of TSBYE were inoculated to a final 153 
concentration of 104 cells/mL. These flasks were incubated under agitation (130 rpm; 154 
Selecta, mod. Rotabit, Barcelona, Spain) at the appropriate temperature until the 155 
stationary growth phase was reached (24 ± 2 h). The stationary phase was chosen 156 
because microorganisms show higher resistance to heat at this stage than at the 157 
exponential phase (Hansen and Rieman, 1963), as well as to match previously published 158 
data (Espina et al., 2011; Espina et al., 2010; Espina et al., 2012; Somolinos et al., 159 
2010). 160 
 161 
2.4. Evaluation of the antimicrobial properties of propolis 162 
Propolis was added, in the form of PDS, to determine its antimicrobial 163 
properties. As the solvent in PDS, propylene glycol did not affect microbial growth or 164 
inactivation under the conditions tested (data not shown); for comparison purposes with 165 
8 
 
previous works, we expressed the concentrations of propolis added in mg of propolis 166 
per mL of treatment medium. 167 
The propolis was screened to determine the minimum inhibitory concentration 168 
(MIC) and minimum bactericidal concentration (MBC) against L. monocytogenes EGD-169 
e and E. coli O157:H7 Sakai. Tubes containing 5 mL of TSBYE and different 170 
concentrations of propolis (0.008–2 mg/mL) were inoculated to a final concentration of 171 
105 cells/mL. A negative control (without microorganisms), positive control (without 172 
propolis), and diluent control (the amount of propylenglicol corresponding to the 173 
maximum propolis concentration assayed (2 mg/mL)) were also prepared. After 24 h of 174 
incubation at the appropriate temperature in a shaking thermostatic bath (Bunsen, mod. 175 
BTG, Madrid, Spain), 100 μL of each tube were spread-plated in tryptic soy agar 176 
(Biolife) with 0.6% yeast extract added (TSAYE). The plates were incubated at 177 
corresponding temperatures for 24 h. The MIC was the lowest concentration of propolis 178 
at which bacteria failed to grow, showing counts equals to the initial concentration. The 179 
MBC was defined as the lowest concentration of propolis that inactivates 99.9% of an 180 
inoculated sample, showing counts below 102 colony-forming units (CFU)/mL. The 181 
evaluations of MIC and MBC were carried out in triplicate.  182 
Moreover, the antimicrobial properties of propolis were evaluated by 183 
determining the bacterial inactivation, as a function of the treatment medium pH. A 184 
vigorous shaking method was used to prepare propolis suspensions in citrate–phosphate 185 
buffers (McIlvaine buffer) at pH 7.0 and 4.0.  186 
Cells from stationary-phase cultures were added at final concentrations of 3 x 187 
107 CFU/mL to buffers, both with and without propolis (0.2 mg/mL). The buffer pH 188 
was not modified as a consequence of adding antimicrobial compounds. Antimicrobial 189 
compound treatments were carried out at 20 ºC for 24 h. Samples were taken at 1, 6, and 190 
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24 h, and the survivors and sub-lethally injured cells were enumerated, as described 191 
below. Previous experiments showed that untreated cells of E. coli O157:H7 Sakai and 192 
L. monocytogenes EGD-e at concentrations of 107 CFU/mL were insensitive to 193 
incubation in citrate–phosphate buffers at pH 7.0 or 4.0 for 24 h at 20 ºC (data not 194 
shown). 195 
 196 
2.5. Measurement of cell inactivation by heat treatments and propolis 197 
Heat and combined treatments were carried out in a specially designed thermo-198 
resistometer, as previously described (Condón et al., 1993). Briefly, this device uses a 199 
thermocouple (Pt 100) to monitor the temperature during the heat treatment and for the 200 
injection of the inoculum. Once the temperature stabilized, 0.2 mL of an adequately 201 
diluted cell suspension was injected with a disposable syringe into the 400-mL 202 
treatment chamber containing the treatment medium under constant agitation. The 203 
initial bacterial concentration was approximately 3 x 107 CFU/mL, in order to match 204 
previously published data (Espina et al., 2010) and to allow for the detection of 5 log10 205 
cycles of inactivation. The treatment media included a sterile McIlvaine buffer of pH 206 
4.0 and commercial apple juice (Don Simón, Murcia, Spain) of pH 3.7, as well as these 207 
media with propolis added (0.1 and 0.2 mg/mL). Samples were taken, and the survivors 208 
were enumerated. 209 
 210 
2.6. Counts of viable cells 211 
After treatment, the samples were adequately diluted in 0.1% w/v peptone water 212 
(Oxoid, Hampshire, England). Next, 0.1-mL samples were pour-plated onto TSAYE, 213 
which was used as a recovery medium. The plates were incubated for 24 h at 37 °C. 214 
After incubation, the CFUs were counted with an improved image analyzer automatic 215 
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counter (Protos; Analytical Measuring Systems, Cambridge, United Kingdom), as 216 
previously described (Condón et al., 1996). Inactivation was expressed in terms of the 217 
extent of reduction in log10 counts (CFU) after any treatment. 218 
 219 
2.7. Determination of sublethally injured cells 220 
After treatment, the samples were also plated onto TSAYE with 4% sodium 221 
chloride (Fisher Scientific, Loughborough, United Kingdom) added (TSAYE-SC), as 222 
well as onto TSAYE with 0.25% bile salts (Oxoid, Hampshire, England) added 223 
(TSAYE-BS), to evaluate the cytoplasmic membrane damage and outer membrane 224 
damage, respectively (Mackey, 2000). These concentrations of sodium chloride and bile 225 
salts were previously determined as the maximum non-inhibitory concentrations (data 226 
not shown) for untreated cells. The samples recovered in the selective media were 227 
incubated for 48 h at 37 °C. After incubation, the CFUs were also counted. The extent 228 
of sub-lethal injury was expressed as the difference between the log10 counts on a non-229 
selective medium (TSAYE) and the log10 counts on selective media (TSAYE-SC and 230 
TSAYE-BS). 231 
 232 
2.8. Resistance parameters to heat and combined processes 233 
Survival curves were obtained by plotting the log10 fractions of survivors versus 234 
the treatment times at constant temperature and propolis concentrations. As linear, 235 
concave upward and concave downward survival curves were observed, a mathematical 236 
model based on a Weibull-like distribution was used. The model is described by the 237 
Mafart equation (Mafart, Couvert, Gaillard, & Leguerinel, 2002): 238 
 239 
Log10 S(t) = −(t / δ) ρ        (1)  240 
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 241 
where S(t) is the survival fraction, t is the holding time (min), δ is the scale parameter 242 
(min), and ρ is the shape parameter (dimensionless). The δ value represents the 243 
treatment time needed to reduce the first 1 log10 cycle of the population. Depending on 244 
the survival curve, the ρ value will be: ρ < 1 (concave upward), ρ = 1 (linear), or ρ > 1 245 
(concave downward). The GraphPad Prism® software (GraphPad Software, Inc., San 246 
Diego, CA, USA) was used to fit the model to the experimental data and to calculate the 247 
δ and ρ parameters.  248 
Thermal death time (TDT) curves were obtained by plotting the log10 of the 249 
times to inactivate 5 log10 cell cycles versus their corresponding heating temperature. 250 
The R2 coefficients and statistical significant differences (t-test and ANOVA) (p = 0.05) 251 
were calculated with GraphPad Prism® software. 252 
 253 
2.9. Sensory test 254 
A sensory test was performed by a panel consisting of 77 untrained judges who 255 
tasted 2 sets of 4 samples each. Each set of 4 samples consisted of commercial apple 256 
juice (Don Simón, Murcia, Spain) with increasing concentrations of propolis added. For 257 
each sample, 20 mL of juice was offered in a cup. The samples were presented in 258 
counter-balanced order, and yogurt was offered as a palate cleanser. For the first set, the 259 
panelists were asked to determine the hedonic acceptance of the 4 coded samples by 260 
ranking them on a 1–9 scale (from “dislike extremely” to “like extremely”); they were 261 
also asked their purchase intention (yes/no). For the second set, the panelists were 262 
shown the added concentrations of propolis in each sample; then, a short summary on 263 
the published health benefits of propolis and their purchase intentions (yes/no) were 264 
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obtained. The results were analyzed statistically with IBP SPSS Statistics 19 (SPSS, 265 
Chicago, IL, USA).  266 
 267 
3. Results and Discussion 268 
 269 
3.1. Bioactive compounds of propolis 270 
Propolis usually contains a variety of chemical compounds, such as polyphenols 271 
(flavonoids, phenolic acids and their esters), terpenoids, steroids, and amino acids 272 
(Kumazawa et al., 2004). Among them, the bioactive properties of propolis have mainly 273 
been associated with its content in polyphenols (Burdock, 1998; Kumazawa et al., 274 
2004). For this reason, total polyphenol content (TPC) and its main group flavonoids 275 
(flavonoid content, FC) were measured in our propolis-based dietary supplement (PDS) 276 
before testing its antioxidant and antibacterial activities. As in other studies, the 277 
quantification of these compounds into groups with the same or similar chemical 278 
structure was preferred to the quantification of individual components because the 279 
former correlates better with biological activity (Jug et al., 2014; Popova et al., 2004). 280 
The chemical composition of propolis depends on the phytogeographic 281 
characteristics of the site of collection, but is also influenced by the use of different 282 
extraction methods and solvents (Burdock, 1998; Cunha et al., 2004; Kumazawa et al., 283 
2004). Furthermore, due to the lack of a standardized extraction process, TPC and FC 284 
can be expressed in different terms, like as a fraction of the dry or concentrated propolis 285 
in the solution (Cunha et al., 2004; Moreira et al., 2008). In our PDS, we determined a 286 
TPC of 82.15 ± 3.53 mg/g CAEs and a FC of 0.096 ± 0.003 mg/g CEs. This TPC is 287 
within the medium-high range, similar to that described for propolis from Greece, 288 
Cyprus, and Spain (Kalogeropoulos et al., 2009; Kumazawa et al., 2013), while the FC 289 
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is low, like that observed in other Mediterranean propolis from Malta, whose bioactive 290 
properties were ascribed to its high concentration of diterpenes (Popova et al., 2011). 291 
Further investigations on the vegetation in the collection site and on the chemical profile 292 
should be performed in order to fully define the chemotype of our propolis. 293 
 294 
3.2. Antioxidant activity of propolis 295 
As a measure of the antioxidant activity, DPPH free radical–scavenging activity 296 
was determined in our PDS, obtaining an IC50 value of 0.055 ± 0.003 mg/mL, which 297 
was within the common range of other analyzed propolis samples (0.030–0.115 mg/mL) 298 
(Jug et al., 2014; Moreira et al., 2008). This result indicated a similar DPPH free 299 
radical–scavenging activity to that of other extensively studied natural antioxidants, 300 
such as origanum and thyme essential oils (Prakash et al., 2015), and resveratrol 301 
derivatives (He and Yan, 2013).  302 
The naturally high antioxidant potential of propolis has been ascribed to the 303 
capacity of polyphenols to reduce the oxidative damage caused by free radicals in 304 
cellular biomolecules (Burdock, 1998). Like the antimicrobial properties of propolis, its 305 
antioxidant activity can also be promoted as being of pharmaceutical interest and as a 306 
potential application in food preservation to help prevent the undesirable effect of 307 
oxidation reactions in foods. 308 
 309 
3.3. Evaluation of the antimicrobial properties of propolis 310 
The antimicrobial activities of propolis were evaluated by determining the MIC 311 
and MBC, as well as by testing microbial inactivation as a function of the treatment 312 
medium pH. As shown in Table 1, L. monocytogenes EGD-e was more sensitive to 313 
propolis than E. coli O157:H7 Sakai, which confirms previous studies pointing to 314 
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Gram-positive bacteria as the most susceptible to propolis (Burdock, 1998). Propolis 315 
showed bacteriostatic and bactericidal activity against L. monocytogenes EGD-e but 316 
only bacteriostatic activity against E. coli O157:H7 Sakai under the concentrations 317 
tested (up to 2 mg/mL of propolis). The comparison of these results with those of other 318 
natural antimicrobials tested under the same experimental conditions shows that 319 
propolis was more effective than citrus, juniper, cypriol, eucalyptus, and rosemary EOs, 320 
but less effective than pennyroyal mint and thyme EOs, as well as individual EO 321 
constituents such as thymol, carvacrol, borneol, and linalool (Ait-Ouazzou et al., 2011; 322 
Ait-Ouazzou et al., 2012; Espina et al., 2011). The strong antimicrobial and antioxidant 323 
activities in our propolis could be partly due to its non-flavonoid TPC, but the 324 
antimicrobial activity of the terpenoids, as well as the possible synergistic interactions 325 
among its major and minor components, are not discarded.  326 
The pH of the treatment medium is one of the major environmental factors 327 
affecting microbial resistance to physical or chemical inactivating agents (Burt, 2004; 328 
Hansen and Rieman, 1963). However, to the best of our knowledge, the influence of 329 
acid pH on the bactericidal effect of propolis has not been previously tested. The action 330 
of propolis (0.2 mg/mL) on the survival of both microorganisms was tested in buffer at 331 
pH 7.0 and 4.0 for 1, 6, and 24 h at 20 ºC (Table 2). The inactivation at pH 7.0 was 332 
coincident with the bactericidal activity that was previously pointed out in Table 1: 333 
While more than 5 log10 cycles of L. monocytogenes EGD-e cells were inactivated after 334 
24 h, less than 1 log10 cycles of E. coli O157:H7 Sakai cells were affected. The 335 
reduction of the treatment medium pH to 4.0 significantly increased the sensitivity of L. 336 
monocytogenes EGD-e to propolis, achieving more than 5 log10 cycles of inactivation in 337 
1 h; however, it hardly affected the resistance of E. coli O157:H7 Sakai, with less than 2 338 
log10 cycles inactivated in 24 h.  339 
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Evaluating the survivors using selective recovery media showed that propolis 340 
caused sub-lethal injuries on the cytoplasmic membranes of most L. monocytogenes 341 
EGD-e after 1 h of incubation at pH 7.0 (Table 2): While 1.3 log10 cycles of cells were 342 
inactivated, 3.7 extra log10 cell cycles were sub-lethally injured. Injured cells were 343 
finally inactivated by propolis after 24 h of incubation at 20 ºC. In contrast, none of the 344 
E. coli O157:H7 Sakai cells were sub-lethally injured at the cytoplasmic or outer 345 
membranes after 24 h of incubation. The higher resistance among Gram-negative 346 
bacteria to certain antimicrobial compounds has been attributed to the presence of an 347 
outer membrane, which acts as a barrier to lipophilic compounds (Burt, 2004). This 348 
outer membrane avoids the action of propolis against the sensitive cytoplasmic 349 
membrane. To the best of our knowledge, no attempts to evaluate sub-lethal injury in 350 
cell membranes of propolis-treated cells using the selective medium plating technique 351 
have been carried out before. 352 
As shown, propolis might perform as an effective antimicrobial against L. 353 
monocytogenes EGD-e at very low doses (0.2 mg/mL) and at both treatment medium’s 354 
pH; however, E. coli O157:H7 Sakai was hardly affected under the same treatment 355 
conditions. Since higher doses of propolis might not be suitable for application by the 356 
food industry, from a sensorial and economical point of view, our goal was to 357 
investigate the application of low doses of propolis in combination with mild heat, in 358 
order to design a new combined process to inactivate 5 log10 cycles of E. coli O157:H7 359 
Sakai. In previous studies, combinations of mild heat and low doses (0.2 µL/mL) of 360 
EOs and EO constituents were investigated, and synergistic effects against E. coli 361 
O157:H7 were described in both laboratory media and fruit juices (Ait-Ouazzou et al., 362 
2012; Ait-Ouazzou et al., 2013; Espina et al., 2014; Espina et al., 2012). For instance, 363 
the combination of mild heat and carvacrol, which is also a constituent of some propolis 364 
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extracts (Segueni et al., 2010), was effective against E. coli O157:H7 suspended in 365 
mango, orange, apple, and tomato juices (Ait-Ouazzou et al., 2013). This combined 366 
process allowed for a significant reduction in the heat treatment intensity, which avoids 367 
undesirable effects on food quality. Therefore, the first step was to demonstrate the 368 
synergism between heat and propolis in laboratory media, and later its persistence in 369 
apple juice as a food matrix. 370 
 371 
3.4. Study of the synergistic effect of heat and propolis in laboratory media 372 
To evaluate the synergistic lethal effect of heat and propolis on E. coli O157:H7 373 
Sakai, the action of each hurdle acting alone was firstly investigated. The experiments 374 
were performed using a McIlvaine buffer of pH 4.0, close to that of fruit juices, in order 375 
to more deeply investigate the mechanisms and kinetics of inactivation.  376 
Fig. 1 shows the survival curves for a heat treatment of 51 ºC by recovering the 377 
survivors on the non-selective TSAYE medium and the selective TSAYE-SC and 378 
TSAYE-BS media. As linear and concave downward survival curves were observed, a 379 
mathematical model based on the Weibull distribution (Mafart et al., 2002) was used to 380 
fit the curves obtained in TSAYE (R2 ≥ 0.92) and to calculate the time needed to 381 
inactivate up to 5 log10 cell cycles (Table 3). The thermal treatment at 51 ºC inactivated 382 
5 log10 cycles of microorganisms in approximately 44 min. Nevertheless, the 383 
inactivation kinetics in the non-selective medium were not linear because a 20 min 384 
“shoulder” was observed, adjusting the ρ value to 2.34. On the other hand, at 20 ºC, the 385 
population of E. coli O157:H7 suspended in a buffer of pH 4.0 with propolis (0.2 386 
mg/mL) added hardly decreased 0.3 log10 cycles after 45 min (data not shown). A dose 387 
of 0.2 mg/mL was chosen for comparing the efficacy of this antimicrobial with others, 388 
such as EOs and their constituents, which were previously tested at the same 389 
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concentrations, alone or in combination with heat treatments, by our research group 390 
(Ait-Ouazzou et al., 2012; Ait-Ouazzou et al., 2013; Espina et al., 2010; Espina et al., 391 
2014; Espina et al., 2012).  392 
Alternatively to the 44 min required for the thermal treatment, the combined 393 
treatment at 51 ºC with 0.2 mg/mL of propolis added inactivated 5 log10 cycles of the 394 
initial population in approximately 1 min (Table 3; Fig. 1). These results demonstrated 395 
that the addition of propolis to the treatment medium before heating achieved more than 396 
4 extra log10 cycles of inactivation after only 1 min of treatment, which means that 397 
propolis and heat acted synergistically, reducing the time needed to inactivate 5 log10 398 
cycles of E. coli O157:H7 by more than 40 times, in comparison with thermal treatment 399 
at the same temperature. From a kinetic of inactivation point of view, and in contrast to 400 
the curves observed for thermal treatments, the survival curves of E. coli O157:H7 after 401 
the combined processes with propolis did not show any shoulder.   402 
The synergism observed when combining mild heat and EOs, or their 403 
constituents, is related to the inactivation of heat-injured cells, especially of those with 404 
damaged outer membranes. Heat damaged the outer membrane, facilitating the access 405 
and/or action of the lipophilic compounds. However, in the presence of propolis, this 406 
hypothesis does not seem to be suitable, since the degree of inactivation reached by the 407 
combined treatment was much greater than that predicted by the survival curves 408 
obtained in TSAYE-BS (Fig. 1). It seems more likely that heat might facilitate the 409 
diffusion of propolis constituents into the lipid phase of the membrane, allowing them 410 
to penetrate the cell and act in the cytoplasm. This was the greatest synergistic effect 411 
observed by our research group when combining mild heat and natural antimicrobials 412 
under the same experimental conditions (Ouazzou et al., 2012; Ait-Ouazzou et al., 2013; 413 
Espina et al., 2010; Espina et al., 2014; Espina et al., 2012). Thus, the combination of 414 
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mild heat and propolis might be proposed for alternative food preservation treatments or 415 
even as a cleaning and disinfection method.  416 
 417 
3.5. Study of the synergistic effect of heat and propolis in commercial apple juice 418 
Microbial heat resistance usually is higher in food than in buffers of the same 419 
pH (Manas and Pagán, 2005). Food components such as salts, sugars, proteins, and fats 420 
might help to protect cells against heat damage. Synergism might also be influenced by 421 
the interaction of food constituents with barriers or microorganisms.  422 
Our results demonstrated that the time needed to inactivate 5 log10 cycles of E. 423 
coli O157:H7 by heat at 51 ºC, when suspended in apple juice, increased from 44 (in 424 
buffer of pH 4.0) to 61 min (in apple juice) (Fig. 2; Table 3). The kinetics of the 425 
inactivation also showed a pronounced shoulder in apple juice; similarly, the survival 426 
curves obtained in TSAYE media required 30% extra time to reach the 5 log10 cycles of 427 
inactivation. The synergism was also reduced, since the time required to achieve the 5 428 
log10 cycles of inactivation increased from 1 (in buffer of pH 4.0) to 9.8 min (in apple 429 
juice) (Table 3). Despite the partial loss of synergism between heat and propolis, the 430 
time to inactivate 5 log10 cycles of E. coli O157:H7 using the combined treatment was 431 
6.25 times shorter than that required when applying heat alone. Thus, the synergism’s 432 
effectiveness between heat and propolis extract was similar to that observed when 433 
applying mild heat and citral to apple juice (Espina et al., 2010) or mild heat and lemon 434 
EO or limonene to orange juice (Espina et al., 2014). 435 
 436 
3.6. Study of the hedonic acceptability of commercial apple juice in the presence of 437 
propolis  438 
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Because sensory evaluation is the key to ensuring compliance with the quality 439 
and marketability requirements of food products, this study aimed to determine an 440 
acceptable threshold concentration of propolis extract in apple juice through a sensory 441 
test. This experiment was carried out before exploring the influence of the treatment 442 
temperature in the efficacy of the combined treatment, in order to evaluate this relevant 443 
aspect with a tolerable propolis dose.  444 
Fig. 3 shows the box-and-whiskers plots corresponding to the hedonic data 445 
collected from the sensory tests when the panelists were not revealed the concentrations 446 
of propolis in each sample. Since not all of the hedonic data could be fitted to a normal 447 
distribution, Kruskal–Wallis tests were performed to compare the results from the 448 
sensory tests. No statistically significant differences were found between the control and 449 
the samples with 0.05 and 0.1 mg/mL of propolis added. On the contrary, the sample 450 
with 0.2 mg/mL of propolis added was significantly less appreciated than the rest of the 451 
samples (p < 0.05). As a conclusion, the apple juice treated with heat and up to 0.1 452 
mg/mL of propolis would be, in terms of hedonic evaluation, as acceptable as a sample 453 
with no propolis extract added (p > 0.05). Moreover, the purchase intention of panelists 454 
did not decrease after knowing the content of propolis in each sample (p > 0.05); on the 455 
contrary, the buying intention for apple juice with 0.05 mg/mL of propolis increased by 456 
22%. This could indicate that the health and pharmaceutical benefits of propolis could 457 
account for the commercialization of propolis-enriched apple juice as a functional food 458 
with good sensory properties, meeting consumers’ demands for healthy, nutritious, and 459 
tasty food. 460 
 461 
3.7. Study of the influence of treatment temperature on the synergistic effect 462 
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Once the synergism of the combined process had been characterized at 51 ºC 463 
and the maximum acceptable hedonic concentration was chosen, the final step was to 464 
elucidate whether the effectiveness of the synergistic effect would be maintained when 465 
reducing the concentration of propolis extract and approaching pasteurization 466 
temperatures. For this purpose, thermal death time (TDT) curves were obtained in apple 467 
juice that was heat treated at 51–63 ºC and with 0.2 mg/mL (reference concentration) 468 
and 0.1 mg/mL (maximum acceptable hedonic concentration) of propolis extract added 469 
(Fig. 4). 470 
Fig. 4 shows the TDT curves obtained from plotting the log10 values of the times 471 
to inactivate 5 log10 cycles for each temperature. This inactivation level matches FDA’s 472 
recommendation for the hygienization of acidic fruit juices (FDA, 2001). The TDT 473 
curves were described by the following equations: 474 
log10 t = −0.1493 ∙ T + 9.42  (R2 = 0.98)   (2) 475 
log10 t = −0.1433 ∙ T + 8.63  (R2 = 0.95)   (3) 476 
log10 t = −0.1905 ∙ T + 10.67  (R2 = 0.94),   (4) 477 
      478 
where t is the time to inactivate 5 log10 of the initial population of E. coli O157:H7 and 479 
T is the temperature of the control thermal treatment (Eq. 2) and the thermal treatments 480 
in the presence of 0.1 mg/mL (Eq. 3) or 0.2 mg/mL propolis (Eq. 4). 481 
As shown in Fig. 4, the synergism observed at 51° C in the presence of the 482 
reference concentration (0.2 mg/mL) of propolis was maintained or even slightly 483 
increased when increasing the thermal treatment up to 57 °C (p ≤ 0.05). The reduction 484 
of propolis concentration from 0.2 to 0.1 mg/mL (maximum acceptable hedonic 485 
concentration) caused a significant reduction in the effectiveness of the combined 486 
process. The synergistic effect observed at 51 °C in the presence of 0.1 mg/mL of 487 
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propolis caused a reduction of 75% in the treatment time, compared to the thermal 488 
treatment acting alone. The synergism was constant in the presence of 0.1 mg/mL of 489 
propolis, when increasing the thermal treatment up to 60 °C, because no statistically 490 
significant differences were observed between the slopes of the TDT curves defined by 491 
Eq. 3 (z = 7.0± 0.7 ºC) and Eq. 2 (z = 6.7 ± 0.2 ºC) (p > 0.05). From these equations, it 492 
can be observed that, at 60 ºC, the combined process also caused a reduction in the 493 
treatment time by 4 times, as observed at 51 ºC. As a consequence, the application of 494 
these combined processes at higher temperatures, such as those used during the current 495 
LTLT (low temperatures–long time) (60 – 65 ºC) pasteurization processes, would likely 496 
result in a similar synergistic effect. The same conclusion was drawn from the 497 
investigation of the effect of temperature on the synergistic inactivation of E. coli 498 
O157:H7 by heat and lemon EO in apple juice (Espina et al., 2012), as well as on 499 
orange EO and limonene in orange juice (Espina et al., 2014). As in those natural 500 
products, the antimicrobial constituents of propolis seem to be resistant to heat 501 
denaturation under the treatment conditions assayed. 502 
Fig. 4 suggests two possibilities for reducing the intensity of thermal treatments. 503 
As the treatment time required to inactivate 5 log10 cycles was reduced by 4 times in the 504 
presence of propolis, the amount of processed apple juice could be increased by more 505 
than four time with the same equipment, with regards to heat treatments without 506 
propolis. On the other hand, the same microbial inactivation levels achieved after 2.8 507 
min of treatment at 60 ºC with no antimicrobials (Eq. 2) were reached in combination 508 
with 0.1 mg/mL of propolis at 57 ºC (Eq. 3)—3 ºC lower. Thus, this decrease in the 509 
treatment temperature to achieve the same inactivation levels is expected to have a 510 
positive impact on the nutritional and organoleptic properties of apple juice (Vikram et 511 
al., 2005), as well as provide advantages for the food industry, such as energy cost 512 
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reductions in achieving the desired safety level. Other demonstrated properties of 513 
propolis, such as its antifungal activity in juices (Koc et al., 2007), could also become 514 
additional advantages to be considered. These results show the potential of propolis in 515 
combination with heat to improve preservation of apple juice. Further research on the 516 
influence of environmental factors, such as pH, food matrix or concentration of propolis 517 
on these synergistic effects, is needed in order to develop secondary and tertiary models 518 
to adequately predict microbial inactivation and to optimize combined processes of heat 519 
treatments in presence of propolis. 520 
 521 
4. Conclusions 522 
This study has characterized the bioactive compounds and analyzed the 523 
antioxidant activity of a propolis-based dietary supplement (PDS) from Spain. The total 524 
phenolic content of the PDS was 82.15 ± 3.53 mg CAEs/g, with an antioxidant activity 525 
(IC50) of 0.055 ± 0.003 mg/mL. Regarding its antimicrobial activity, this study has 526 
revealed the greater inactivation and occurrence of sub-lethal injury by propolis 527 
treatments at acidic pH and on a Gram-positive bacterium than at neutral pH and on a 528 
Gram-negative bacterium. From these results, propolis might perform as an effective 529 
antimicrobial against L. monocytogenes EGD-e at very low doses (0.2 mg/mL), 530 
although it hardly affected E. coli O157:H7 Sakai.  531 
Strong synergistic, lethal effects against E. coli O157:H7 Sakai were shown 532 
using mild heat and propolis, since the addition of 0.2 mg/mL of propolis to a pH 4.0 533 
buffer reduced the heating time needed to inactivate 5 log10 cell cycles by more than 40 534 
times. In apple juice, the controlled incorporation of 0.1 mg/mL of propolis reduced the 535 
thermal treatment required to reach the goal inactivation level by at least 4 times or 3 536 
ºC. As this propolis concentration was sensorially acceptable, a less intense 537 
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pasteurization process would be expected to improve the organoleptic and nutritional 538 
properties of apple juice, besides increasing its industrial performance. Furthermore, 539 
given the phenolic content and high antioxidant properties of propolis (besides other 540 
possible health benefits), the present study contemplates its incorporation into apple 541 
juice, not only to improve the preservation methodology, but also as a means of creating 542 
a new “green-labeled” functional food. 543 
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 686 
Figure Legends 687 
 688 
Fig. 1. Survival curves of Escherichia coli O157:H7 Sakai (initial concentration: 689 
3 x 107 CFU/mL) to a heat treatment at 51 ºC in citrate-phosphate buffer of pH 4.0, and 690 
recovered in TSAYE (○), TSAYE-SC (□), TSAYE-BS (◊), or recovered in TSAYE 691 
after a combined treatment of heat and propolis (0.2 mg/mL) (●). Data represent the 692 
means ± standard error of the mean (error bars) of at least three independent 693 
experiments. 694 
 695 
Fig. 2. Survival curves of Escherichia coli O157:H7 Sakai (initial concentration: 696 
3 x 107 CFU/mL) to a heat treatment at 51 ºC in apple juice, and recovered in TSAYE 697 
(○), TSAYE-SC (□), TSAYE-BS (◊), or recovered in TSAYE after a combined 698 
treatment of heat and of propolis (0.2 mg/mL) (●). Data represent the means ± standard 699 
error of the mean (error bars) of at least three independent experiments. 700 
 701 
Fig. 3. Box-and-whisker plots showing the hedonic data values for apple juices 702 
with increasing concentrations of propolis (0, 0.05, 0.1 and 0.2 mg/mL). In each plot, 703 
horizontal lines correspond to the minimum value, the percentiles 25, 50 and 75 704 
(ranging from 1 to 9 in the scale), and the maximum value. The asterisk represents 705 
statistically significant differences with the 0 % juice. 706 
 707 
Fig. 4. Log10 times (min) for inactivation of 5 log10 cycles of Escherichia coli 708 
O157:H7 (initial concentration, 3 x 107 CFU/mL) at different treatment temperatures in 709 
30 
 
apple juice, with no propolis added (●), with 0.1 mg/mL (○) or 0.2 mg/mL (□) of 710 
propolis added. Cells were recovered in TSAYE. 711 
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Table 1. Minimum inhibitory concentration (MIC) and minimum 1 
bactericidal concentration (MBC) of propolis (mg/mL). 2 
Strains Tested  MIC MBC 
Listeria monocytogenes EGD-e 0.05 0.11 
Escherichia coli O157:H7 Sakai 0.2 >0.2 
 3 
  4 
2 
 
Table 2. Log10 cycles of inactivation (mean ± standard deviation) of Escherichia coli O157:H7 Sakai and Listeria monocytogenes EGD-e 5 
after a treatment with propolis (0.2 mg/mL) at 20 ºC. Cells were treated in citrate-phosphate buffer of pH 4.0 or pH 7.0 and recovered in TSAYE, 6 
TSAYE-SC and TSAYE-BS. 7 
Treatment 
Medium 
Recovery 
Medium 
 
Strains tested 
 
E. coli O157:H7 Sakai L. monocytogenes EGD-e 
1 h 6 h 24h 1 h 6 h 24 h 
pH 4 
TSAYE 0.29 ± 0.27 0.91 ± 0.72 1.58 ± 0.27 > 5.0 > 5.0 > 5.0 
TSAYE-SC 0.39 ± 0.30 0.99 ± 0.64  2.01 ± 0.88 > 5.0 > 5.0 > 5.0 
TSAYE-BS 0.54 ± 0.45 1.13 ±0.62 1.71 ± 0.94    
pH 7 
TSAYE 0.08 ± 0.11 0.16 ± 0.12 0.53 ± 0.16 0.38 ± 0.13 1.27 ± 0.31 > 5.0 
TSAYE-SC 0.32 ± 0.17 0.33 ± 0.18 0.89 ± 0.13 0.71 ± 0.27 5.07 ± 1.33 > 5.0 
TSAYE-BS 0.30 ± 0.20 0.57 ± 0.30 0.86 ± 0.07    
  
8 
9 
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Table 3. Regression parameters (δ, time to inactivate 5 log10 cell cycles, and ρ) and the 10 
goodness of fit (R2 and Root Mean Square Error (RMSE)) estimated from the fit of 11 
equation 1 to experimental data of Escherichia coli O157:H7 Sakai (initial 12 
concentration: 3 x 107 CFU/mL) heat-treated at 51 ºC and recovered in TSAYE. CI: 13 
Confidence Interval.  14 
Treatment  
Medium 
δ (min) 
 (95% CI) 
Time for 5-log10 
red. (min)     
(95% CI) 
ρ (95% CI) R2 RMSE 
McIlvaine buffer pH 4 21.96 (19.96-23.96) 43.70 (42.09-45.31) 2.34 (1.98-2.70) 0.93 0.85 
McIlvaine buffer pH 4 
+ propolis (0.2 mg/mL) 0.052 (0.026-0.078) 0.97 (0.77-1.17) 0.55 (0.43-0.67) 0.84 1.08 
Apple juice 30.86 (27.85-33.88) 61.22(58.88-63.55) 2.35 (1.96-2.75) 0.92 0.85 
Apple juice   +   
propolis (0.2 mg/mL) 1.02 (0.75-1.23) 9.80 (8.80-10.81) 0.71 (0.61-0.81) 0.87 0.99 
 15 
